China lab monkey shortage tightens as biotech demand rebounds

Joinn Laboratories reports that China's recovering biotech fundraising and out-licensing activity has significantly increased demand for primate research models, tightening supply of lab monkeys. The shortage could constrain preclinical drug development timelines and raise costs for Chinese biotech firms. The extent of the supply gap and its impact on drug pipelines remain uncertain.